Fresubin Energy Drink by Fresenius - liquid nutrition steadies everyday calorie intake

Fresubin Energy Drink sits on the bedside table, a small 200 ml bottle with a faint vanilla smell that fills the room before the first sip. Designed by Fresenius Kabi dietitian Dr. Sabine Krämer and her team, it turns clinical nutrition into a manageable daily ritual for patients.

High-calorie in a small volume

Fresubin Energy Drink is a high-calorie, oral nutritional supplement providing about 300 kcal per 200 ml bottle, with roughly 20 percent of energy from protein and the rest mainly from carbohydrates and fats. This concentration helps people who can only drink limited amounts to still reach meaningful calorie targets during the day.

Fresenius Kabi positions the drink primarily for patients at risk of malnutrition, for example older adults, oncology patients or people recovering from surgery who cannot cover their needs with normal food alone. The product is lactose free and gluten free, a detail that dietitians like Dr. Krämer highlight because it simplifies menu planning in mixed hospital wards.

Flavors, packaging and daily use

Fresubin Energy Drink is available in several flavors, including vanilla, chocolate, strawberry and cappuccino, all sold in 4 x 200 ml packs for hospitals, nursing homes and home nutrition. Each bottle uses a screw cap and is ready to drink, and Fresenius Kabi recommends serving it chilled to improve taste acceptance.

Clinical nutrition nurse Petra Lang describes how she often hands the cool bottle to patients with a short explanation and a smile, pointing out the 300 kcal on the label. For many, that number becomes a tangible target: one bottle with breakfast, another in the afternoon, supplementing ordinary meals without feeling overwhelming.

Nutritional profile and indications

According to Fresenius Kabi’s product information, Fresubin Energy Drink offers a balanced mix of macronutrients with around 11 to 12 g of protein per bottle, alongside fats and carbohydrates to support energy density. Micronutrients such as vitamins and minerals are included to help cover daily requirements when intake from normal food is insufficient.

The drink is classified as a food for special medical purposes and is intended for use under medical supervision. Indications listed by Fresenius Kabi include disease-related malnutrition and increased energy requirements, for example in oncology or geriatrics, where energy needs rise while appetite drops.

Distribution and reimbursement

Fresubin Energy Drink is distributed across Europe and other regions through pharmacies, wholesale partners and direct supply channels to hospitals and nursing facilities. In Germany, statutory health insurance can reimburse medical nutrition like Fresubin when prescribed by a physician, provided the patient meets defined malnutrition criteria.

Fresenius Kabi’s sales teams work with hospital pharmacists and dietitians to integrate Fresubin Energy Drink into nutrition protocols. The product typically appears alongside other Fresubin drinks on ward trolleys, making it a recurring feature in daily rounds rather than a one-off intervention.

Role within Fresenius Kabi’s portfolio

Fresubin Energy Drink belongs to the broader Fresubin oral nutritional supplement line, which Fresenius Kabi presents as a key pillar of its clinical nutrition business alongside enteral tube feeds and parenteral solutions. The company highlights the Fresubin brand in its marketing materials and in clinical education events targeting dietitians and physicians.

CEO Michael Sen has emphasized in presentations that clinical nutrition is a stable business contributing to recurring revenue, particularly in aging societies. While he does not single out Fresubin Energy Drink in capital markets days, Fresubin products as a group are mentioned as part of the strategy to strengthen the Kabi segment’s profitability.

Market environment and competition

The oral nutritional supplement market in Europe is competitive, with products such as Ensure and Nutridrink vying for shelf space alongside Fresubin in pharmacies and hospital formularies. Fresenius Kabi positions Fresubin Energy Drink with its specific energy density, flavor range and clinical evidence generated in malnutrition studies.

For dietitians like Dr. Krämer, the practical question is often whether patients finish the bottle. Taste acceptance, bottle design and serving temperature play a direct role in compliance rates, which in turn influence whether nutritional targets are met and clinicians stick with the product in their protocols.

Digital support and patient information

Fresenius Kabi offers online information on Fresubin Energy Drink and related products through its Fresubin website, including guidance for patients and carers on when and how to use oral nutrition. Printable PDF leaflets and simple dosage tables show how to distribute drinks across the day and combine them with meals.

On patient forums, caregivers exchange experiences of Fresubin Energy Drink, discussing flavor preferences and strategies to encourage reluctant drinkers, such as mixing vanilla with coffee or serving strawberry over ice. This informal feedback loop helps refine how clinicians talk about the product and adjust practical recommendations at the bedside.

Context and the Fresenius share

Within Fresenius SE & Co. KGaA, Fresubin Energy Drink sits in the Fresenius Kabi division, which focuses on clinical nutrition, generic drugs and medical devices. The steady demand for oral nutritional supplements like Fresubin is one factor behind the recurring revenue base that investors track in Kabi’s segment reporting and in group guidance. On Xetra, the Fresenius SE & Co. KGaA share trades in euros and reflects expectations for how well this kind of everyday clinical product can defend margins in an aging European market.